These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 9476965)
1. Characterization and tumorigenicity of human neuroblastoma cells transfected with the IL-2 gene. Corrias MV; Basso S; Meazza R; Musiani P; Santi L; Bocca P; Occhino M; Ferrini S; Pistoia V Cancer Gene Ther; 1998; 5(1):38-44. PubMed ID: 9476965 [TBL] [Abstract][Full Text] [Related]
2. NK cell-mediated anti-tumor immune response to human prostate cancer cell, PC-3: immunogene therapy using a highly secretable form of interleukin-15 gene transfer. Suzuki K; Nakazato H; Matsui H; Hasumi M; Shibata Y; Ito K; Fukabori Y; Kurokawa K; Yamanaka H J Leukoc Biol; 2001 Apr; 69(4):531-7. PubMed ID: 11310838 [TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo characteristics of human squamous cell carcinoma of the head and neck cells engineered to secrete interleukin-2. Nagashima S; Reichert TE; Kashii Y; Suminami Y; Chikamatsu K; Whiteside TL Cancer Gene Ther; 1997; 4(6):366-76. PubMed ID: 9408607 [TBL] [Abstract][Full Text] [Related]
4. Dissimilar anti-tumour reactions induced by tumour cells engineered with the interleukin-2 or interleukin-15 gene in nude mice. Di Carlo E; Meazza R; Basso S; Rosso O; Comes A; Gaggero A; Musiani P; Santi L; Ferrini S J Pathol; 2000 Jun; 191(2):193-201. PubMed ID: 10861581 [TBL] [Abstract][Full Text] [Related]
5. Fractalkine (CX3CL1)- and interleukin-2-enriched neuroblastoma microenvironment induces eradication of metastases mediated by T cells and natural killer cells. Zeng Y; Huebener N; Fest S; Weixler S; Schroeder U; Gaedicke G; Xiang R; Schramm A; Eggert A; Reisfeld RA; Lode HN Cancer Res; 2007 Mar; 67(5):2331-8. PubMed ID: 17332365 [TBL] [Abstract][Full Text] [Related]
6. The tumorigenicity of IL-2 gene-transfected murine M-3D melanoma cells is determined by the magnitude and quality of the host defense reaction: NK cells play a major role. Schneeberger A; Koszik F; Schmidt W; Kutil R; Stingl G J Immunol; 1999 Jun; 162(11):6650-7. PubMed ID: 10352282 [TBL] [Abstract][Full Text] [Related]
7. Successful immunogene therapy using colon cancer cells (colon 26) transfected with plasmid vector containing mature interleukin-18 cDNA and the Igkappa leader sequence. Yoshimura K; Hazama S; Iizuka N; Yoshino S; Yamamoto K; Muraguchi M; Ohmoto Y; Noma T; Oka M Cancer Gene Ther; 2001 Jan; 8(1):9-16. PubMed ID: 11219497 [TBL] [Abstract][Full Text] [Related]
9. Antitumor efficacy of a human interleukin-12 expression plasmid demonstrated in a human peripheral blood leukocyte/human lung tumor xenograft SCID mouse model. Hess SD; Egilmez NK; Shiroko J; Bankert RB Cancer Gene Ther; 2001 May; 8(5):371-7. PubMed ID: 11477457 [TBL] [Abstract][Full Text] [Related]
10. High level expression of the homeobox gene HB24 in a human T-cell line confers the ability to form tumors in nude mice. Deguchi Y; Kehrl JH Cancer Res; 1993 Jan; 53(2):373-7. PubMed ID: 8093351 [TBL] [Abstract][Full Text] [Related]
11. Antitumor effects of cytolytic T lymphocytes (CTL) and natural killer (NK) cells in head and neck cancer. Whiteside TL; Chikamatsu K; Nagashima S; Okada K Anticancer Res; 1996; 16(4C):2357-64. PubMed ID: 8816835 [TBL] [Abstract][Full Text] [Related]
12. Interleukin-21 triggers both cellular and humoral immune responses leading to therapeutic antitumor effects against head and neck squamous cell carcinoma. Nakano H; Kishida T; Asada H; Shin-Ya M; Shinomiya T; Imanishi J; Shimada T; Nakai S; Takeuchi M; Hisa Y; Mazda O J Gene Med; 2006 Jan; 8(1):90-9. PubMed ID: 16097036 [TBL] [Abstract][Full Text] [Related]
13. Induction of immunity in peripheral tissues combined with intracerebral transplantation of interleukin-2-producing cells eliminates established brain tumors. Iwadate Y; Yamaura A; Sato Y; Sakiyama S; Tagawa M Cancer Res; 2001 Dec; 61(24):8769-74. PubMed ID: 11751397 [TBL] [Abstract][Full Text] [Related]
14. A novel metastatic animal model reflecting the clinical appearance of human neuroblastoma: growth arrest of orthotopic tumors by natural, cytotoxic human immunoglobulin M antibodies. Engler S; Thiel C; Förster K; David K; Bredehorst R; Juhl H Cancer Res; 2001 Apr; 61(7):2968-73. PubMed ID: 11306475 [TBL] [Abstract][Full Text] [Related]
16. Human tumor antigen-specific T lymphocytes and interleukin-2-activated natural killer cells: comparisons of antitumor effects in vitro and in vivo. Whiteside TL; Sung MW; Nagashima S; Chikamatsu K; Okada K; Vujanovic NL Clin Cancer Res; 1998 May; 4(5):1135-45. PubMed ID: 9607570 [TBL] [Abstract][Full Text] [Related]
17. Adeno-associated virus vector-mediated delivery of pigment epithelium-derived factor restricts neuroblastoma angiogenesis and growth. Streck CJ; Zhang Y; Zhou J; Ng C; Nathwani AC; Davidoff AM J Pediatr Surg; 2005 Jan; 40(1):236-43. PubMed ID: 15868591 [TBL] [Abstract][Full Text] [Related]
18. Impaired tumorigenicity of human pancreatic cancer cells retrovirally transduced with interleukin-12 or interleukin-15 gene. Yoshida Y; Tasaki K; Miyauchi M; Narita M; Takenaga K; Yamamoto H; Yaaguchi T; Saisho H; Sakiyama S; Tagawa M Cancer Gene Ther; 2000 Feb; 7(2):324-31. PubMed ID: 10770643 [TBL] [Abstract][Full Text] [Related]
19. Natural killer cell-dependent suppression of systemic spread of human lung adenocarcinoma cells by monocyte chemoattractant protein-1 gene transfection in severe combined immunodeficient mice. Nokihara H; Yanagawa H; Nishioka Y; Yano S; Mukaida N; Matsushima K; Sone S Cancer Res; 2000 Dec; 60(24):7002-7. PubMed ID: 11156403 [TBL] [Abstract][Full Text] [Related]
20. Adenovirus-mediated interleukin-18 mutant in vivo gene transfer inhibits tumor growth through the induction of T cell immunity and activation of natural killer cell cytotoxicity. Hwang KS; Cho WK; Yoo J; Seong YR; Kim BK; Kim S; Im DS Cancer Gene Ther; 2004 Jun; 11(6):397-407. PubMed ID: 15044962 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]